Komipharm International

041960 · KOSDAQ · ₩041960 · 코미팜

₩9,070▲ ₩320 (3.66%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me

Filings

  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서

    Predicted impact: Low

    Oct 27, 2026Open on DART
  • Amended: Major sales or supply contract[기재정정]단일판매ㆍ공급계약체결Sep 10, 2026Open on DART
  • Half-year report (Jun 2026)반기보고서 (2026.06)Aug 13, 2026Open on DART
  • Quarterly report (Mar 2026)분기보고서 (2026.03)May 14, 2026Open on DART
  • Amended: Major sales or supply contract[기재정정]단일판매ㆍ공급계약체결Apr 8, 2026Open on DART
  • Annual general meeting results정기주주총회결과Mar 26, 2026Open on DART
  • Notice on Grant of Stock Purchase Options주식매수선택권부여에관한신고Mar 26, 2026Open on DART
  • Audit report submitted감사보고서제출Mar 18, 2026Open on DART
  • Added attachment: Annual report (Dec 2025)[첨부추가]사업보고서 (2025.12)Mar 18, 2026Open on DART
  • Amended: Shareholders' meeting called[기재정정]주주총회소집결의Mar 11, 2026Open on DART
  • [Amended] Change of 30% or More in Sales or Profit Structure (15% or More for Large Companies)[기재정정]매출액또는손익구조30%(대규모법인은15%)이상변동Mar 11, 2026Open on DART
  • Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Mar 11, 2026Open on DART
  • Notice of shareholders' meeting주주총회소집공고Mar 11, 2026Open on DART
  • Shareholders' meeting called주주총회소집결의Mar 5, 2026Open on DART
  • Derivatives Trading Loss Incurred (Voluntary Disclosure)파생상품거래손실발생(자율공시)Feb 20, 2026Open on DART
  • Change in Revenue or Profit/Loss Structure of 30% or More (15% or More for Large Companies)매출액또는손익구조30%(대규모법인은15%)이상변동Feb 20, 2026Open on DART
  • Report on Treasury Stock Acquisition Results자기주식취득결과보고서Feb 6, 2026Open on DART
  • Amended: Major sales or supply contract[기재정정]단일판매ㆍ공급계약체결Jan 9, 2026Open on DART
  • Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Dec 16, 2025Open on DART
  • Quarterly report (Sep 2025)분기보고서 (2025.09)Nov 14, 2025Open on DART
  • Adjustment of Conversion Price전환가액의조정Nov 7, 2025Open on DART
  • Share buyback decision주요사항보고서(자기주식취득결정)Nov 5, 2025Open on DART
  • Major sales or supply contract단일판매ㆍ공급계약체결Oct 14, 2025Open on DART
  • Amended: Major sales or supply contract[기재정정]단일판매ㆍ공급계약체결Sep 30, 2025Open on DART
  • Report on Treasury Stock Acquisition Results자기주식취득결과보고서Sep 22, 2025Open on DART
  • Amended: 5%+ holding report[기재정정]주식등의대량보유상황보고서(약식)Sep 15, 2025Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(약식)Sep 8, 2025Open on DART
  • Half-year report (Jun 2025)반기보고서 (2025.06)Aug 13, 2025Open on DART
  • Securities Issuance Results (Voluntary Disclosure)증권발행결과(자율공시)Aug 6, 2025Open on DART
  • Convertible bond issue decision주요사항보고서(전환사채권발행결정)Jul 30, 2025Open on DART
  • Acquisition of Convertible Bonds (Including Overseas Convertible Bonds) After Issuance and Before Maturity전환사채(해외전환사채포함)발행후만기전사채취득Jul 7, 2025Open on DART
  • Share buyback decision주요사항보고서(자기주식취득결정)Jun 20, 2025Open on DART
  • Report on Treasury Stock Acquisition Results자기주식취득결과보고서Jun 20, 2025Open on DART
  • Major Matters Report (Exercise of Convertible Bond Call Option by Third Party)주요사항보고서(제3자의전환사채매수선택권행사)May 27, 2025Open on DART
  • Quarterly report (Mar 2025)분기보고서 (2025.03)May 14, 2025Open on DART
  • [Amendment] Exercise of Conversion Right[기재정정]전환청구권행사Apr 29, 2025Open on DART
  • Exercise of Conversion Rights전환청구권행사Apr 23, 2025Open on DART
  • Annual general meeting results정기주주총회결과Mar 26, 2025Open on DART
  • Amended: Share buyback decision[기재정정]주요사항보고서(자기주식취득결정)Mar 26, 2025Open on DART
  • Share buyback decision주요사항보고서(자기주식취득결정)Mar 26, 2025Open on DART
  • Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Mar 26, 2025Open on DART
  • Audit report submitted감사보고서제출Mar 18, 2025Open on DART
  • Annual report (Dec 2024)사업보고서 (2024.12)Mar 18, 2025Open on DART
  • Amended: Major sales or supply contract[기재정정]단일판매ㆍ공급계약체결Mar 13, 2025Open on DART
  • Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Mar 11, 2025Open on DART
  • Notice of shareholders' meeting주주총회소집공고Mar 11, 2025Open on DART
  • Shareholders' meeting called주주총회소집결의Feb 25, 2025Open on DART
  • Change in Revenue or Profit/Loss Structure of 30% or More (15% or More for Large Companies)매출액또는손익구조30%(대규모법인은15%)이상변동Feb 19, 2025Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jan 23, 2025Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jan 7, 2025Open on DART

Titles in Korean until English translations are added.

Also known as: Komipharm International / 코미팜 / 041960 / KRX:041960

Source: KRX statistical information